Thursday, November 19, 2026

Equity Corporate Actions Alert #2026 - 839
Information Regarding the Change of Control of Rallybio Corporation (RLYB) and Avenzo Therapeutics, Inc.

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Resources


The merger of Rallybio Corporation (RLYB) and Avenzo Therapeutics, Inc. resulting in a change of control is expected to close on Friday, November 20, 2026. Pre-merger shareholders of Rallybio Corporation Common Stock (RLYB) will receive a non-transferable Contingent Value Right (CVR) and a Special Return of Capital Cash Dividend of $13.90, to be issued to shareholders on a pre-reverse split basis. The CVR distribution will not be quoted EX by Nasdaq. The EX date for the Special Cash Dividend will be Monday, November 23, 2026. Prior to the completion of the merger with Avenzo Therapeutics, Inc., the company's Common Stock (RLYB) will undergo a one-for-two (1-2) reverse stock split. Following the completion of the merger, the company’s common stock will undergo a change of name, symbol & CUSIP. Monday, November 23, 2026, is the effective date for the 1-2 reverse stock split, and the name, symbol, and cusip change, and is the EX date for the Special Cash Return of Capital cash dividend.

The details of the CVR and Special dividend distribution are as follows:

Non-Transferable CVR distribution

Company Name & Issue Type: Rallybio Corporation Common Stock
Symbol: RLYB
CUSIP: 75120L209
Rate of Distribution: One (1) non-transferable Contingent Value Right (CVR) for each share held.
EX Date: Will not be quoted Ex
Record Date: November 5, 2026
Payment Date: November 23, 2026

Special Dividend:

Company Name & Issue Type: Rallybio Corporation Common Stock
Symbol: RLYB
CUSIP: 75120L209
Rate of Distribution: $13.90 per share; Return of Capital.
EX Date: November 23, 2026
Record Date: November 5, 2026
Payment Date: November 30, 2026

The details of the name, symbol, & CUSIP changes are as follows:

Current Company Name & Issue Type: Rallybio Corporation Common Stock
New Company Name & Issue Type: Avenzo Therapeutics, Inc. Common Stock
Current CUSIP: 75120L209
New CUSIP: 053928107
Current Symbol: RLYB
New Symbol: AVZO
Ratio of Reverse Split: 1 for 2
Marketplace Effective Date: Monday, November 23, 2026

If you would like to register as a market maker in AVZO, contact Nasdaq Trading Services at +1 212 231 5100.



Email Alert Subscriptions:
Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets. Create and maintain a profile for updating alert preferences and contact information. Visit the enrollment form on the Nasdaq Trader website and sign up today! Please note that if you choose to unsubscribe from an email list, you may no longer receive potentially critical emails from the NASDAQ Stock Market regarding Nasdaq's trading and data products, regulatory issues or marketplace initiatives. To unsubscribe, also click on the enrollment form

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.